# Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

> **NCT04181463** · PHASE2 · NOT_YET_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 112 (estimated)

## Conditions studied

- Malignant Neoplasm

## Interventions

- **DRUG:** Isopropyl Alcohol
- **OTHER:** Placebo
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT04181463
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11-05
- **Primary completion:** 2028-12-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04181463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04181463, "Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04181463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*